Huaren Pharmaceutical: Hongta Innovation plans to reduce its holdings by no more than 1%
I'm PortAI, I can summarize articles.
According to the announcement from Huaren Pharmaceutical, Hongta Innovation plans to reduce its holdings through centralized bidding trading within three months after the announcement of the reduction plan, starting from 15 trading days after the announcement date (i.e., from August 26, 2025, to November 25, 2025), by no more than 1% of the company's total share capital, which is no more than 11.82 million shares
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments